RxDoctor Payments DataLook up a doctor →

William Nelson, MD

Cardiovascular Disease · St Paul, MNNPI 1497728711

Payments from drug & device makers

$1,120,080in general payments, 2019–2025

Across 538 payments — averaging $2081.93 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • CSL Behring$398K
  • Novartis$397K
  • Amgen$96K
  • Esperion Therapeutics, Inc.$88K
  • Boehringer Ingelheim International GmbH$61K
  • Boston Scientific$60K
  • plus $20K from 3 others

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,120,080 in reported general payments places this provider in the 95th percentile of 451 cardiovascular disease providers in Minnesota.

See all cardiovascular disease providers in Minnesota

Medicare billing

Part B allowed, 2024
$48,145
Medicare patients
722
Services billed
1,029

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other cardiovascular disease in St Paul

See the full list for Minnesota

Where these figures come from

Is this you, or does something look wrong? →